Attovia Therapeutics Inc
Clinical trials sponsored by Attovia Therapeutics Inc, explained in plain language.
-
New eczema drug ATTO-3712 enters early human safety trials
Symptom relief OngoingThis early-stage study tests a new drug called ATTO-3712 in healthy adults and people with atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo and are monitored with clinic visi…
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New drug ATTO1310 tested for eczema and itch relief
Symptom relief OngoingThis early-stage study tests a new drug called ATTO1310 to see if it is safe and how the body processes it. It includes healthy adults, people with atopic dermatitis (eczema), and those with long-term itching. Participants receive either the drug or a placebo and are monitored fo…
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC